Treatment of growing teratoma syndrome

N Engl J Med. 2009 Jan 22;360(4):423-4. doi: 10.1056/NEJMc0808558.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Disease Progression
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Neoplasms, Second Primary / drug therapy*
  • Neoplasms, Second Primary / metabolism
  • Piperazines / therapeutic use*
  • Pyridines / therapeutic use*
  • Retinoblastoma Protein / metabolism
  • Teratoma / drug therapy*
  • Teratoma / metabolism
  • Young Adult

Substances

  • Antineoplastic Agents
  • Piperazines
  • Pyridines
  • Retinoblastoma Protein
  • Cyclin-Dependent Kinases
  • palbociclib

Associated data

  • ClinicalTrials.gov/NCT00141297